Clinical Trial Update: A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC [NA]

View source ↗

Summary

A multicenter trial is evaluating YSQTG versus simulated agents with neoadjuvant chemoradiotherapy or chemoimmunotherapy for esophageal squamous cell carcinoma;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Simulated agents
• YSQTG

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Esophageal Squamous Cell Carcinoma (ESCC) | NA | Status: ENROLLING_BY_INVITATION